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Identifying routinely recorded markers of poor health in patients with dementia may help 
treatment decisions and evaluation of earlier outcomes in research. Our objective was to 
determine whether a set of credible markers of dementia-related health could be identified 
from primary care electronic health records (EHR). 
Methods 
The study consisted of (i) rapid review of potential measures of dementia-related health used 
in EHR studies; (ii) consensus exercise to assess feasibility of identifying these markers in 
UK primary care EHR; (iii) development of UK EHR code lists for markers; (iv) analysis of a 
regional primary care EHR database to determine further potential markers; (v) consensus 
exercise to finalise markers and pool into higher domains; (vi) determination of 12-month 
prevalence of domains in EHR of 2328 patients with dementia compared to matched patients 
without dementia. 
Results 
Sixty-three markers were identified and mapped to 13 domains: Care; Home Pressures; 
Severe Neuropsychiatric; Neuropsychiatric; Cognitive Function; Daily Functioning; Safety; 
Comorbidity; Symptoms; Diet/Nutrition; Imaging; Increased Multimorbidity; Change in 
Dementia Drug. Comorbidity was the most prevalent recorded domain in dementia (69%). 
Home Pressures was the least prevalent domain (1%). Ten domains had a statistically 
significant higher prevalence in dementia patients, one (Comorbidity) was higher in non-





EHR captures important markers of dementia-related health. Further research should assess if 
they indicate dementia progression. These markers could provide the basis for identifying 
individuals at risk of faster progression and outcome measures for use in research. 





Dementia significantly impacts individuals, their families, and health and social care services 
(World Health Organisation, 2017; Cahill, 2019). Over 800,000 people live with dementia in 
the UK (Pink, O’Brien, Robinson & Longson, 2018), and its impact is likely to increase with 
a growing ageing population (Prince et al, 2013; Matthews et al, 2016). In response, the UK 
government initiated a National Dementia Strategy (Department of Health, 2009; Pickett et 
al, 2018), and Prime Minister’s National Dementia Challenge (Department of Health, 2012) 
that included calls for delaying its consequences, such as nursing home admissions, hospital 
admissions, and early mortality (Dodd, Cheston, Ivanecka, 2015). It was recognised that 
primary care would have a central role in delivering this dementia strategy (Burns, 2012; 
Parmar et al, 2014; Greaves et al, 2015; Thyrian et al, 2016). 
An important contribution to primary care management of a condition is understanding of its 
course and the factors that influence prognosis. Central to this is knowledge about markers 
relevant to primary care that indicate poorer health and progression. One potential 
longitudinal data resource for identifying common patterns of disease-related health is 
primary care Electronic Health Records (EHR). Primary care EHR contain information 
routinely recorded from patient contacts with primary care services including coded reason 
for consultation, prescriptions, referrals, investigations, and tests. The vast majority of the 
UK population are registered with a general practitioner (GP) providing a rich source of data 
on individuals over time. EHR databases have been used in dementia research previously, 
notably to ascertain factors associated with onset (Dunn, Mullee, Perry & Holmes, 2005; Rait 
et al, 2010; Cooper et al, 2015; Walters et al, 2016; Dell'Agnello et al, 2018). However, to 
date there has been little research using EHR to examine changes in health and prognosis in 
patients with dementia, despite evidence of patient variability over time in relation to long 
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term outcomes such as hospital admissions and mortality (Poblador-Plou et al, 2014; 
Alzheimer’s Association, 2015). 
In order to determine common patterns of progression in dementia and understand prognostic 
factors based on EHR, there is a need to first identify markers of health that are related to 
dementia that can be reliably detected using primary care EHR. This will not only help to 
identify those with poorer prognosis and help guide management of the disease but would 
also allow the use of routine data to evaluate interventions that aim to improve outcomes for 
those with dementia, significantly reducing time and cost of research studies in dementia. The 
aim of the current study was to investigate whether a set of credible markers of dementia-
related health can be identified from routine EHR primary care data, and whether these 
individual markers can be grouped into larger domains. We also determined whether the 
recorded prevalence of the derived domains were higher in patients with dementia compared 
to those without dementia. 
Methods 
The study consisted of four stages (Figure 1). 
Stage 1: Initial identification of pool of potential markers of dementia-related health 
A rapid literature review was conducted including a systematic search to identify markers of 
dementia-related health (for example, dementia severity and outcomes) that had been used in 
previous EHR studies worldwide. The review was conducted in accordance with PRISMA 
(Preferred Reporting Items for Systematic Reviews and Meta-Analyses), and registered on 
PROSPERO (CRD: 42016053455). Searches were undertaken from inception date to 2017 in 
AGELINE, AMED, CINAHL, EMBASE, Ethos, PsychINFO, MEDLINE and Web of 




health/research/thin-database] and CPRD [https://www.cprd.com/Bibliography]). The search 
consisted of keywords and MeSH terms for dementia, and individual EHR databases (CPRD, 
GPRD, Kaiser Permanente, QResearch, ResearchOne, SAIL, THIN). Bibliographies of 
included research studies were hand searched. Studies had to follow participants post 
diagnosis of dementia, and use data from EHRs. Papers were excluded if they were: 1) not 
freely available in English language, 2) non-human studies, 3) editorials, guidelines, policies 
and/or non peer-reviewed, 4) not available in full-text after contacting the author. EHR data 
were defined as information extracted from routinely collected records of patient interactions 
with healthcare providers which were recorded in electronic format.  
Retrieved citations were screened against these inclusion and exclusion criteria independently 
by two reviewers (STB, ST), with consensus reached where disagreements arose via 
discussion with a third reviewer (PCa). All extracted markers were systematically sorted 
(STB, ST, PCa) into domains specified by the International Consortium for Health Outcome 
Measurement (ICHOM) Standard Set for Dementia (ICHOM, 2016). These domains include 
clinical status, safety, sustainability, carer, symptoms, medication, quality of life, functioning. 
This allowed assessment of the coverage of markers compared to this comprehensive 
framework for dementia. 
Stage 2: Consensus-based evaluation of potential marker identification in UK primary care 
EHR systems  
An expert consensus meeting [n=7, consisting of general practitioners (GPs), experts in 
dementia, primary care EHR researchers] considered whether the markers identified from the 
review could feasibly be identified within UK primary care EHR, and whether there were 
other potential markers of dementia-related health that may be identifiable within the EHR. 
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At this stage, all markers were treated independently (i.e. markers of a similar or overlapping 
nature were not combined unless considered identical in nature). 
In UK primary care, the Read code hierarchical system is currently used to record processes 
of care, symptoms, and diagnoses within EHR. The consensus group considered whether the 
markers identified from the review were likely to be coded and used within UK primary care 
EHR. Broad lists of Read codes were derived for those markers thought to be feasibly 
identifiable within primary care EHR based on previous UK-based EHR research studies (for 
example [Baker, Cook, Arrighi & Bullock, 2010; Davies, Kehoe, Ben-Shlomo & Martin, 
2011; Grant, Drennan, Rait, Petersen & Illiffe, 2013; Imfeld , Bodmer , Schuerch, Jick & 
Meier, 2013; Cook et al, 2015]), existing databases of Read code lists,[Springate et al, 2014; 
Keele Medical Record Research website, https://www.keele.ac.uk/mrr], and additional 
searches of the Read code hierarchy. The consensus group felt that neuropsychiatric 
symptoms (for example, psychosis, depression) associated with dementia may be understood 
as part of dementia and therefore not coded separately. Therefore, we also included 
prescriptions of relevant medication to define these neuropsychiatric symptoms as in previous 
EHR studies (Dennis et al, 2017; Lewis, Werbeloff, Hayes, Howard & Osborn, 2018).  
Stage 3: Refinement of markers, determination of further markers, and final allocation to 
domains 
The application of the Read code lists developed in Stages 1 and 2 were tested on the records 
of patients with dementia included in a regional primary care EHR database (Consultations in 
Primary Care Archive (CiPCA)). CiPCA has ethical approval as a research database from 
North West Haydock Research Ethics Committee (ref 17/NW/0232) and contains the 
pseudonymised EHR of patients attending 9 GP practices in North Staffordshire (annual 
registered population approximately 90,000 patients). These practices have undergone regular 
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assessments on quality of their electronic morbidity recording since 1998 (Porcheret et al, 
2004; Jordan et al, 2007; Jordan et al 2014). 
We included the medical records of patients in CiPCA with a recorded diagnosis (new or 
ongoing) of any type of dementia between 2000 and 2015. Diagnosis of dementia was based 
on a Read code list developed previously through consensus of GP and EHR researchers 
(Burton, Campbell, Jordan, Strauss & Mallen, 2012), and code lists used in other studies 
(Brown et al, 2016; Browne et al, 2017; Pham et al, 2018). Coding of dementia in UK 
primary care EHR has been validated previously (Pujades-Rodriguez et al, 2018). Index date 
was defined as the date of earliest record of dementia within the period 2000-2015. Patients 
were censored at the end of 2015 or at the point their registration with the general practice 
ended if prior to the end of 2015.  
We determined the number of patients with dementia who had at least one recorded code for 
each marker after their index date, and the most commonly recorded codes from the relevant 
code lists for each marker. Based on patterns of use of codes, markers were renamed, if 
necessary, and code lists refined and reduced from the initial broad lists. Markers deemed to 
be similar in terms of care, symptoms, or diagnosis were merged at this stage.  
Hypothesis-free analysis was performed to identify other symptoms, morbidities, or processes 
of care recorded in the first 12 months after index date that were associated with dementia. 
Each patient with dementia was age, gender, and practice-matched to a randomly selected 
patient without a recorded diagnosis of dementia in the period 2000-2015. Patients without 
dementia were given the same index date as their matched patient’s index date. All codes at 
the third level of the five level Read code hierarchy were examined (for example, code N05 
“Osteoarthritis and allied disorders” is a third level code within Chapter N “Musculoskeletal 
and connective tissue diseases”). A code was taken forward if its prevalence was ≥1% 
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(indicating relevance at a population level), and its association with dementia was either 
statistically significant (unadjusted p<0.05) or the odds ratio was greater than 1.3 or less than 
0.77 (suggesting a potential association with dementia with a small effect size, Olivier & 
Bell, 2013) derived from conditional logistic regression. Codes meeting the criteria were then 
combined with existing markers (from Stages 1 and 2) if they were judged as similar, or 
included as separate markers if deemed plausible.   
Markers were then remapped to domains based on the ICHOM Standard Set for Dementia 
(ICHOM, 2016). A final expert consensus group (n=15) made final adjustments by 
combining or splitting markers, making definitions of markers and domains more precise, and 
allocating markers to domains as necessary. Read codes and medications lists are available 
from www.keele.ac.uk/mrr/morbiditydefinitions/. 
Stage 4: Analysis of final list of domains 
The final stage used the records of patients with dementia and matched non-dementia patients 
to determine the period prevalence of the final list of markers and domains in the 12 months 
after index date. In order to allow all patients the opportunity for a full 12 months follow-up 
prior to the end of the study period (end of 2015), we excluded patients with dementia (and 
their matched unexposed patients) with their first recorded diagnosis in 2015. All other 
patients were censored at the earliest of 12 months follow-up or the date their registration 
ended at the practice (therefore patients who left the practice or died before the end of the 12 
months were retained to avoid healthy survivor bias). Prevalence of a marker was estimated 
as the number of patients with at least one coded record of the marker in the 12 months after 
index date, divided by the total number of patients with (or without) dementia. To determine 
prevalence by domain, the numerator was defined as the number of patients with at least one 
coded record of any marker from that domain in the 12 months after index date, and the 
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denominator was the total number of patients with (or without) dementia. Associations of 
domains with a dementia diagnosis were assessed using univariable binary logistic 
regression, with robust variance estimators to account for the matching of dementia and non-
dementia patients.  
Patient and Public Involvement 
The Patient and Public Involvement and Engagement Dementia Group within the School of 
Primary, Community and Social Care at Keele University contributed to the development of 
the rapid literature review. The Dementia Group consisted of people with a diagnosis of 
dementia and caregivers of those with dementia (current and previously). 
Results 
Stage 1: Initial identification of a pool of potential markers of dementia-related health 
3167 unique citations were retrieved as a result of the review. Screening removed 3133 
papers (appendix 1), leaving 34 relevant papers (53% USA, 35% UK, 12% other). Data 
extraction identified 153 potential markers which were mapped to eight ICHOM domains 
(35% to symptoms domain, 22% sustainability and time to full time care, 17% medication, 
15% safety, 3% clinical status, 3% functioning, 3% quality of life, 2% carer).   
Stage 2: Consensus-based evaluation of potential marker identification in UK primary care 
EHR systems  
The consensus exercise group agreed that 115 of the 153 markers were feasibly identifiable 
within UK primary care EHR either directly (for example, a fall or fracture Read code) or as 
a proxy (for example, a Read code indicating bedbound as an indication of daily functioning 
ability). Example items that were considered not feasible included changes in brain volume 
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using magnetic resonance imaging (MRI), quality of life measures, and details related to the 
caregiver. Initial Read code lists were then derived for the included markers.  
Stage 3: Refinement of markers, determination of further markers, and final allocation to 
domains 
There were 2714 patients with a recorded dementia diagnosis (new or ongoing) in the CIPCA 
database between 2000 and 2015.  The lists of potential marker Read codes developed in 
Stage 2 were tested in the records of these patients. Further, 1622 codes at the third level of 
the Read code hierarchy were found to be recorded in the twelve-month period from index 
date and hence included in the hypothesis-free analyses. Of these 1622 Read codes, 282 had a 
prevalence of ≥1% and had an association (odds ratio>1.3 or <0.77, or p<0.05) with a 
dementia diagnosis. Of these 282 codes, 93 were already included in code lists for markers 
previously identified in Stages 1-2. A further 139 codes were excluded, mainly as they were 
codes for laboratory tests or general investigations being undertaken, routine monitoring, or 
administration and so unlikely to indicate aspects of dementia-related health. The remaining 
50 codes included a range of comorbidities and symptoms and additional codes to those 
already identified around advanced directives and shared decision making. These were 
assessed alongside the 115 markers and their code lists derived in Stages 1-2, and the markers 
and domains further refined. This included merging markers of a similar or overlapping 
nature, updating code lists for markers, renaming of markers, and remapping markers to 
domains. The provisional markers and domains were then presented at the final consensus 
meeting. This led to a final set of 63 markers mapped to 13 domains (table 1).  
Stage 4: Analysis of final list of domains 
2328 patients had a recorded dementia diagnosis (new or ongoing) prior to 2015 and hence 
were included in the Stage 4 analysis. Mean age was 80.8 (SD 8.31) years and 65% were 
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female (table 2). The majority (98% of those with a type recorded) of dementia patients were 
diagnosed with Alzheimer’s or vascular dementia. The proportion of patients that had a full 
12 months of follow-up after index date was lower in dementia patients compared to the 
matched non-dementia patients (75% vs 85%). 
The 12-month period prevalence for the final 13 domains is given in table 3. Having a record 
of one of the specified comorbidities (for example, cardiovascular, diabetes) was the most 
prevalent domain in both dementia (69%) and non-dementia patients (74%), with Home 
Pressures being the least prevalent domain (1% in both groups). Ten of the domains had a 
statistically significant higher prevalence in dementia patients compared with non-dementia 
patients. Aside from the Change in Dementia Drug domain, the Cognitive Function (odds 
ratio (OR) 9.25; 95% CI 7.47, 11.47), Severe Neuropsychiatric (7.14; 5.73, 8.89) and Care 
(4.87; 3.92, 6.05) domains had the strongest associations with dementia. The odds of having a 
recorded comorbidity were lower in dementia compared to non-dementia patients (OR 0.77, 
95% CI 0.69, 0.87), and two domains (Home Pressures and Diet/Nutrition) showed no 
association with dementia. 
The period prevalence of the individual markers is shown in table 4. The most prevalent 
markers in dementia patients were ‘Depression, Anxiety, Stress’ (39%), ‘Musculoskeletal 
pain’ (31%), ‘Hypertension’ (26%), and ‘Severe Mental Illness’ and ‘Poor Diet’ (both 24%). 
Markers that were more prevalent in dementia compared to non-dementia patients included 
‘Carer’, and ‘Advanced Directive’ in the Care domain; ‘Severe Mental Illness’ in the Severe 
Neuropsychiatric domain; ‘Depression, Anxiety, Stress‘ and ‘Sleep Problems’ in the 
Neuropsychiatric domain; ‘Memory Loss’ and ‘Confusion’ in the Cognitive Function 




This study shows that it is feasible to identify a number of potentially important markers of 
health in patients with diagnosed dementia using information routinely recorded in UK 
primary care. The markers and domains were generally found to be commonly recorded in 
the primary care records of patients with dementia (12-month period prevalence of twelve of 
the thirteen domains exceeded 10%) suggesting these markers and domains are relevant to 
this population.  
This study combined a systematic search of EHR dementia-based research, mapping to a 
robust framework of outcomes related to dementia (ICHOM, 2016), expert consensus 
meeting to assess the relevance and applicability to primary care data in the UK, and testing 
within a localised primary care EHR database including exploratory (hypothesis-free) 
analysis to identify further markers. All codes and domains were further refined by a 
concluding expert consensus meeting. This led to a set of markers/domains identified within 
EHR that relate to the primary health care experience of those with dementia, and map to 
broader (non-primary care) health care outcomes. The reported 12-month period prevalence 
of the domains indicates these factors occurred at a frequency that make the potential to use 
them in future development of progression measures practical and plausible.  
Comparison to other recent large EHR UK-based studies show comparable figures on age, 
gender, dementia type, prescriptions, and general comorbidity rates in both those with 
dementia and comparable aged cohorts without dementia (Guthrie, Clark & McCowan, 2010; 
Dennis et al, 2017; Lewis, Werbeloff, Hayes, Howard & Osborn, 2018). This suggests the 
findings of this current study are likely to be generalizable to the primary care consultation 
population within the UK, however further research should assess generalisability, 
particularly in countries where different primary care healthcare systems operate.  
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There are some limitations to the study. Whilst improvements have been made in the 
detection of dementia within primary care (Eichler et al, 2015), there may be individuals in 
our comparison group with undiagnosed or unrecorded dementia (Eichler et al, 2014; Lang et 
al, 2017). Any such misclassification might mean the strength of the associations of domains 
with dementia are underestimated. There may be differences in the prevalence of markers and 
domains by dementia sub-type, as has been shown with mortality rates (Garcia-Ptacek et al, 
2014). Another limitation associated with the use of consultation-based EHR is that often 
only one condition is coded (usually the most prominent) in a consultation, even though older 
adults may consult for multiple reasons, therefore some information on multi-morbidity may 
be missing or have been added as “free text” which was not included in this current analysis.  
Examination of the study findings in relation to the ICHOM Dementia Standard Set 
(ICHOM, 2016) shows successful identification of markers and domains indicative of aspects 
of clinical status, safety, functioning, care, symptoms, and medication. Results show 
associations with dementia were particularly strong for the domains relating to care, severe 
neuropsychiatric conditions, and cognitive function, all of which have been shown previously 
to relate to long term outcomes such as nursing home admission, hospitalisation, and 
mortality in non-EHR based studies (Connors et al, 2016; Lewis, Werbeloff, Hayes, Howard, 
& Osborn, 2018; Christensen & White, 2006). Further findings are also clinically 
informative, for example, common markers in the Daily Functioning domain are mobility and 
limitation problems, and in the Safety domain are falls and fractures. Similarly, our findings 
show a high prevalence of comorbidity and particularly symptoms in those with dementia 
indicating increased health burden, with previous EHR research showing an association of 
increasing number of chronic comorbidities with hospitalisation in patients with dementia 
(Browne, Edwards, Rhodes, Brimicombe, & Payne, 2017). These findings are all likely to 
reflect the increased vulnerability in this population (Kulmala, Nykänen, Mänty, & 
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Hartikainen, 2014), and whilst general population EHR-based measures exist to identify 
vulnerability (e.g. Electronic Frailty Index; Clegg et al, 2016), these have not been tested in 
the dementia population and the domains/markers within this study are specific to dementia.  
While the domains mapped onto key dementia outcome criteria proposed by the ICHOM 
Dementia Standard Set (ICHOM, 2016), there are potential markers not routinely recorded in 
primary care EHR. For example, although the Cognitive Function domain contains markers 
of cognition and memory loss, it does not contain information regarding the actual level of 
cognitive ability or activities of daily living (ADL). The Care domain includes markers of 
shared decision making and additional care, but does not include information on social 
relationships, levels of formal and informal care, and caregiver burden. Improved collection 
of cognitive and ADL function, care provision and caregiver issues would help primary care 
further identify poorer dementia-related health. This may be aided in the future by technology 
which allows the incorporation of data from personal mobile devices that monitor health and 
wellbeing, and that allows a more widespread and smarter sharing of information between 
service providers (health, social care, third sector, government).  
This is the first study to establish a feasible pool of markers of dementia-related health that 
are retrievable from primary care EHR, that have been grouped into wider domains to allow 
assessment across key areas of dementia-related health, and may allow assessment of 
dementia progression in individual patients. The next step in terms of research is to establish 
whether they are valid predictors of future adverse outcomes such as hospitalisation and 
death, work that we are undertaking currently in a UK-wide national primary care EHR 
dataset. If this validity is established, then the potential usefulness of these markers to clinical 
practice will lie in their capacity to provide evidence-based information to support shared 
decision-making by patients, their carers and clinicians, either by highlighting early in the 
course of the disease the presence of modifiable risk factors that can be targeted for 
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intervention or by highlighting patients at higher risk of poor long-term outcomes who would 
benefit from prioritisation of resources and care at an early stage. Recording of these markers 
and domains may assist in tailoring care to individuals’ health needs based on areas of 
vulnerability, as well as highlighting patients early after diagnosis who appear to be 
accumulating markers which may indicate increased progression of dementia and may benefit 
from more targeted management including referral to other services. Such information could 
also be used at the population level for supporting planning and policy decisions on care 
provision. These domains and markers may also have potential value as outcomes in clinical 
trials and prognostic studies of the progression of dementia in the short and long-term, where 
studying long-term outcomes such as mortality and nursing home admission is unrealistic or 
impractical. The advantage of EHR data is that they are available in all primary care settings 
and are by definition updated as part of routine care. Our set of markers provide a clear 
starting-point for studies to evaluate the usefulness of prognostic data in practice and a 
framework for improving the range and quality of data within these domains.         
This study has shown that EHR capture many domains and specific markers that are 
important indicators of health for persons with dementia. This research has the potential to 
provide clinically useful information to identify individuals with dementia at risk of more 
rapid progression, and a readily available method that may be useful as an outcome measure 
in future research (e.g. trials) or in ‘natural experiments’ that evaluate changes to practice in 
dementia care.  
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Table 1. Final list of markers nested within domains with examples 
Domain Marker Examples 
Care Additional Help Home help, day care 
Care Carer Evidence has a carer in records 
Care Shared Decision Making Shared decision making 
Care Advanced Directive Advanced care planning 
Home Pressures Home Pressures Marital problems, family bereavement/row 
Severe Neuropsychiatric           Severe Mental Illness Psychosis, schizophrenia, anti-psychotic drug 
Severe Neuropsychiatric           Sectioned Sectioned Form completed/fee paid 
Severe Neuropsychiatric           Crisis Mental crisis plan, referral to crisis team 
Severe Neuropsychiatric           Suicidal Suicidal, high/medium suicide risk 
Neuropsychiatric Depression, Anxiety, 
Stress 
Depression, anxiety, stress, anti-depressant drug 
Neuropsychiatric Aggressive Behaviour Aggressive/abusive behaviour 
Neuropsychiatric Sleep Problems Insomnia, nightmares, hypnotic/anxiolytic drug 
Neuropsychiatric Behavioural Issues Behavioural problem, disinhibited behaviour 
Neuropsychiatric Low Mood Low mood, tearful, worried, lack of 
concentration 
Neuropsychiatric Wandering Wanders during day/night 
Cognitive Function Cognition Cognitive decline, mentally vague 
Cognitive Function Memory Loss Memory loss, amnesia, poor memory 
Cognitive Function Confusion Confusion, delirium, disorientated 
Cognitive Function Aphasia Aphasia, speech therapy/defect, stammer 
Daily Functioning Bedbound Bedbound, bed-ridden 
Daily Functioning Wheelchair Provision of/independent in wheelchair 
Daily Functioning Severe mobility limitation Housebound, chairbound, zimmer frame 
Daily Functioning Mobility – Less Severe 
Limitation 
Mobility poor, walking stick,  gait abnormality 
Daily Functioning Pressure Sore Pressure sore, decubitus ulcer 
Daily Functioning Driving Unfit to drive, advised about driving 
Daily Functioning Difficulty in Eating  Eating problem, dependent for eating 
Daily Functioning Difficulty Handling 
Finance 
Needs help handling financial affairs 
Daily Functioning Personal Care Limitation Dependent for dressing/toilet/bathing 
Daily Functioning Stairs Limitation Difficulty managing stairs, need help on stairs 
Safety Fall Recorded fall 
Safety Fracture Recorded fracture (excl. skull) 
Safety Intracranial Injury Skull fracture, concussion 
Safety Safety Assessment Falls risk assessment, home safety advice 
Comorbidity Cardiovascular Myocardial infarction, ischaemic heart disease 
Comorbidity Stroke Stroke, cerebral infarction 
Comorbidity Parkinson’s Disease Parkinson’s disease 
Comorbidity Motor Neurone Disease Motor Neurone disease 
Comorbidity Diabetes Diabetes mellitus (type I or II) 
Comorbidity Epilepsy Epilepsy, grand mal/petiti mal, fit frequency 
Comorbidity Asthma / COPD Asthma, COPD, chronic bronchitis 
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Comorbidity Musculoskeletal Pain Osteoarthritis, regional pain, rheumatoid arthritis 
Comorbidity Anaemia Iron deficiency anaemia, Vitamin B12 deficiency 
Comorbidity Ocular Cataract, retinopathy, glaucoma, blindness 
Comorbidity Hypertension Essential hypertension, hypertensive disease 
Comorbidity Candidiasis Candidiasis, thrush 
Symptoms Dizziness Dizziness, vertigo, hypotension, giddiness 
Symptoms Incontinence Incontinent of urine/faeces, urgency micturition 
Symptoms Constipation / IBS Constipation, irritable bowel syndrome (IBS) 
Symptoms Diarrhoea Diarrhoea, loose stools 
Symptoms Urinary Retention of urine, haematuria, dysuria 
Symptoms Neurological Fit (no epilepsy record), blackout 




Symptoms Oral Health Stomatitis, poor oral hygiene, sore mouth 
Symptoms Swallowing Difficulty swallowing liquids/solids, dysphagia 
Symptoms Hearing Loss Deafness, hearing loss/impairment 
Symptoms “Feels Unwell” Recorded ‘Feels unwell’ 
Diet/Nutrition Poor Diet Advice re diet, high fat diet, dietician referral 
Diet/Nutrition Nutrition Vitamin/iron deficiency, osteomalacia 
Diet/Nutrition Weight Loss Weight decreasing/loss, underweight 
Diet/Nutrition Dietary Supplement Dietary supplement 
Imaging Imaging X-ray, MRI, ECG, DXA, angiogram, CAT scan 
Increased Multimorbidity  Increase in Polypharmacy Increase in count of different drugs prescribed 
Change in Dementia Drug Change in Dementia-
related Drug 





Table 2 – Demographic characteristics for patients included in Stage 4 analysis, n (%) unless 
stated 
 Dementia Non-Dementia 
n 2328 2328 




  910 (39) (60a) 
  574 (25) (38a) 
    29 (1)    (2a) 
  815 (35) 
N/A 
Gender  Male   
   Female 
  805 (35) 
1523 (65) 
  805 (35)  
1523 (65) 
Age: Mean (SD) 80.8 (8.31) 80.8 (8.31) 
Full 12 month follow-up 1752 (75) 1969 (85) 
Length of follow-up: Mean (SD) days 319 (95) 334 (85) 
a Excluding Unknown from denominator; b Parkinson’s, Lewy Body, Frontotemporal, 
Huntington’s; c Includes where type of dementia is unspecified or recorded as “Senile 





Table 3 – 12-month period prevalence of final derived marker domains, n (%) 
 Dementia Non-Dementia ORa (95% CI) 
n 2328 2328  
Care   414 (18)     99 (4)  4.87 (3.92, 6.05) 
Home Pressures     28 (1)     29 (1) 0.97 (0.57, 1.63) 
Severe Neuropsychiatric   574 (25)   102 (4) 7.14 (5.73, 8.89) 
Neuropsychiatric 1170 (50)   574 (25) 3.09 (2.73, 3.50) 
Cognitive Function   713 (31)   106 (5) 9.25 (7.47, 11.47) 
Daily Functioning   267 (11)   148 (6) 1.91 (1.55, 2.35) 
Safety   645 (28)   483 (21) 1.46 (1.30, 1.65) 
Comorbidity 1600 (69) 1723 (74) 0.77 (0.69, 0.87) 
Symptoms   803 (34)   634 (27) 1.41 (1.24, 1.60) 
Diet/Nutrition   913 (39)   894 (38) 1.04 (0.93, 1.16) 
Imaging   604 (26)   476 (20) 1.36 (1.19, 1.56) 
Increased Multimorbidityb 1223 (53) 1028 (44) 1.40 (1.25, 1.57) 
Change in Dementia Drugb   653 (28)     19 (<1) Not calculated 




Table 4 – 12-month period prevalence of final list of markers, n (%) 
Domain Marker Dementia Non-
Dementia 
 n 2328 2328 
Care Additional Help     24 (1)     20 (<1) 
Care Carer   236 (10)     37 (2) 
Care Shared Decision Making     60 (3)     11 (<1) 
Care Advanced Directive   232 (10)     62 (3) 
Home Pressures Home Pressures     28 (1)     29 (1) 
Severe Neuropsychiatric           Severe Mental Illness   562 (24)   101 (4) 
Severe Neuropsychiatric           Sectioned / Crisis / Suicidalb     19 (<1) a 
Neuropsychiatric Depression, Anxiety, Stress   919 (39)   448 (19) 
Neuropsychiatric Aggressive Behaviour     21 (<1) a 
Neuropsychiatric Sleep Problems   497 (21)   229 (10) 
Neuropsychiatric Behavioural Issues     22 (<1) a 
Neuropsychiatric Low Mood     31 (1)     34 (1) 
Neuropsychiatric Wandering     10 (<1) a 
Cognitive Function Cognition   229 (10) a 
Cognitive Function Memory Loss   315 (14)     41 (2) 
Cognitive Function Confusion   199 (9)     55 (2) 
Cognitive Function Aphasia     57 (2)     13 (<1) 
Daily Functioning Mobility – Severe Limitationc     98 (4)     44 (2) 
Daily Functioning Mobility – Less Severe Limitation   108 (5)     70 (3) 
Daily Functioning Pressure Sore     53 (2)     15 (<1) 
Daily Functioning Driving     14 (<1)     16 (<1) 
Daily Functioning Personal Care Limitationd     24 (1)       5 (<1) 
Daily Functioning Stairs Limitation     24 (1)       8 (<1) 
Safety Fall   362 (16)   211 (9) 
Safety Fracture   154 (7)     98 (4) 
Safety Intracranial Injury     63 (3)     22 (<1) 
Safety Safety Assessment   275 (12)   269 (12) 
Comorbidity Cardiovascular   395 (17)   483 (21) 
Comorbidity Stroke   125 (5)     61 (3) 
Comorbidity Parkinson’s Disease     66 (3)     27 (1) 
Comorbidity Motor Neurone Disease a a 
Comorbidity Diabetes   343 (15)   329 (14) 
Comorbidity Epilepsy     48 (2)     21 (<1) 
Comorbidity Asthma / COPD   217 (9)   293 (13) 
Comorbidity Musculoskeletal Pain   720 (31)   813 (35) 
Comorbidity Anaemia   158 (7)   134 (6) 
Comorbidity Ocular   210 (9)   228 (10) 
Comorbidity Hypertension   604 (26)   852 (37) 
Comorbidity Candidiasis     59 (3)     37 (2) 
Symptoms Dizziness   138 (6)   125 (5) 
Symptoms Incontinence   172 (7)     73 (3) 
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Symptoms Constipation / IBS   195 (8)   125 (5) 
Symptoms Diarrhoea   129 (6)     86 (4) 
Symptoms Urinary   144 (6)   129 (6) 
Symptoms Neurological     19 (<1) a 
Symptoms Chest pain (Non-cardiovascular)     96 (4)   102 (4) 
Symptoms Oral Health     17 (<1)       5 (<1) 
Symptoms Swallowing     38 (2)     30 (1) 
Symptoms Hearing Loss   101 (4)   126 (5) 
Symptoms “Feels Unwell”     47 (2)     32 (1) 
Diet/Nutrition Poor Diet   554 (24)   721 (31) 
Diet/Nutrition Nutrition   138 (6)     78 (3) 
Diet/Nutrition Weight Loss     89 (4)     36 (2) 
Diet/Nutrition Dietary Supplement   369 (16)   174 (7) 
Imaging Imaging   604 (26)   476 (20) 
Increased Multimorbidity Increase in Polypharmacye 1223 (53) 1028 (44) 
Change in Dementia Drug Change in Dementia-related Druge   653 (28)     19 (<1) 
a Less than 5 cases; b Markers combined due to low frequency; c Includes Wheelchair, 
Bedbound, and Severe mobility limitation due to low frequency; d Personal care limitation 
includes Difficulties in eating and handling finance due to low frequency; e Compared to 
previous 12 months 











Identification of pool of potential 
markers of dementia-related health 
Stage 1 
Systematic search of literature to 
identify relevant EHR dementia research 
Rapid review and synthesis of evidence 
Potential markers mapped to existing 
framework of outcomes for dementia 
Assessment of markers relevant to 
UK primary care EHR system 
153 markers 
Stage 2 
Expert consensus evaluation of feasibility 
of marker identification in UK primary 
care EHR systems 
Develop draft lists of EHR codes and 
prescriptions within UK primary care EHR 
that match to identified markers 
115 markers 
Marker refinement, addition and 
aggregation to domains 
Stage 3 
Testing of application of code lists in a 
cohort of patients with dementia 
diagnosis 
Hypothesis-free analysis to determine 
other EHR codes associated with 
dementia  
Examine potential overlap of markers 
and merge markers where feasible 
Expert consensus exercise to finalise 
markers, code lists, and domains 
63 markers in 13 
domains 
Determine prevalence of domains 
and association with dementia 
Stage 4 
